Julie Cramer, PhD (Clinical Research Strategies)
Operation
Director of Clinical and Regulatory Affairs, Clinical Research Strategies
Dr. Cramer earned her PhD from the University of Pittsburgh in Pathology, with a focus on intestinal stem cells and their link to intestinal cancer. When the opportunity came to join a local life sciences startup that had licensed an in vitro diagnostic for cancer from the University of Pittsburgh, she embraced the challenge and quickly came to understand how it takes careful management of a cross-disciplinary team to navigate the often-turbulent entrepreneurial waters.
Dr. Cramer then returned to her alma mater to work in commercial translation at the University of Pittsburgh’s Innovation Institute. Acting as liaison to the University’s close clinical partner, UPMC, Dr. Cramer managed diverse programs, including digital health and immunotherapy, to enable nascent technologies to mature into valuable intellectual property ready for licensing.
Dr. Cramer is passionate about supporting companies through the entire life cycle of commercialization, including clinical study development and maintenance, regulatory submission strategy and partnering.
Dr. Cramer has been an active member of Women In Bio since 2013, serving as a mentor for the MAPS program and as chair of the Pittsburgh Chapter in 2018.
